'Septrin psychosis' among renal transplant patients with Pneumocystis jirovecii pneumonia

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 5, 2011, Pages 1117-1119

  Walker, Lauren E ^a   Thomas, Sherine ^a   McBride, Catherine ^a   Howse, Matthew ^a   Turtle, Lance C W ^a   Vivancos, Roberto ^b   Beeching, Nick J ^a   Beadsworth, Michael B J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Adverse drug event; Psychosis; Renal failure; Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CASE REPORT; CONFUSION; DRUG WITHDRAWAL; EPIDEMIC; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PARANOIA; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PSYCHOSIS; RETROSPECTIVE STUDY; UNITED KINGDOM;

ADULT; AGED; ENGLAND; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MENTAL DISORDERS; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; TRANSPLANTATION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 79954624219     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr050     Document Type: Article

References (12)

1. De Boer MGJ, Bruijnesteijn van Coppenraet LES, Gaasbeek A et al. An outbreak of Pneumocystis jirovecii pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis 2007; 44: 1143-9.
2. Gianella S, Haeberli L, Joos B et al. Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis 2010; 12: 1-10.
3. Komano Y, Harigai M, Koike R et al. Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. Arthritis Rheum 2009; 61: 305-12.
4. Safrin S, Finkelstein DM, Feinberg J et al. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group. Ann Intern Med 1996; 124: 792-802.
5. Helweg-Larsen J, Benfield T, Atzori C et al. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. J Antimicrob Chemother 2009; 64: 1282-90.
6. Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001; 21: 1125-41.
7. McCue JD, Zandt JR. Acute psychoses associated with the use of ciprofloxacin and trimethoprim-sulfamethoxazole. Am J Med 1991; 90: 528-9.
8. Saidinejad M, Ewald MB, Shannon MW. Transient psychosis in an immune-competent patient after oral trimethoprim-sulfamethoxazole administration. Pediatrics 2005; 115: 739-41.
9. Weis S, Karagulle D, Kornhuber J et al. Cotrimoxazole-induced psychosis: a case report and review of literature. Pharmacopsychiatry 2006; 39: 236-7.
10. Gregor JC, Zilli CA, Gotlib IH. Acute psychosis associated with oral trimethoprim sulfamethoxazole therapy. Can J Psychiatry 1993; 38: 56-8.
11. Mermel LA, Doro JM, Kabadi UM. Acute psychosis in a patient receiving trimethoprim sulfamethoxazole intravenously. J Clin Psychiatry 1986; 47: 269-70.
12. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.